Showing results (41-50 of 325) with videos related to
Sort By:
Pageof 33
Journal of Neurosurgery|May 5, 2009
Equal contribution of increased intracranial pressure and subarachnoid blood to cerebral blood flow reduction and receptor upregulation after subarachnoid hemorrhage. Laboratory investigationSaema Ansar, Lars EdvinssonBMC Neuroscience|September 17, 2008
Enhanced expressions of microvascular smooth muscle receptors after focal cerebral ischemia occur via the MAPK MEK/ERK pathwayAida Maddahi, Lars EdvinssonTherapeutic Advances in Neurological Disorders|December 24, 2010
Possible sites of action of the new calcitonin gene-related peptide receptor antagonistsSajedeh Eftekhari, Lars EdvinssonArchives of Dermatological Research|February 15, 2014
Topical non-peptide antagonists of sensory neurotransmitters substance P and CGRP do not modify patch test and prick test reactions: a vehicle-controlled, double-blind pilot studyJoanna Wallengren, Lars EdvinssonJournal of the Renin-Angiotensin-Aldosterone System : JRAAS|January 18, 2017
Evidence for a cyclic AMP-dependent pathway in angiotensin AT1-receptor activation of human omental arteriesHoa Ytterberg, Lars EdvinssonStroke|November 23, 2007
Subtype activation and interaction of protein kinase C and mitogen-activated protein kinase controlling receptor expression in cerebral arteries and microvessels after subarachnoid hemorrhageSaema Ansar, Lars EdvinssonCephalalgia : an International Journal of Headache|September 1, 2017
Distribution of CGRP and CGRP receptor components in the rat brainKarin Warfvinge, Lars EdvinssonThe Journal of Headache and Pain|October 9, 2010
Neurogenic inflammation: a study of rat trigeminal ganglionKim Anker Kristiansen, Lars EdvinssonNeurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|May 1, 2010
CGRP receptor antagonism and migraineLars Edvinsson, Tony W HoJournal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|November 20, 2014
MEK1/2 inhibitor U0126 but not endothelin receptor antagonist clazosentan reduces upregulation of cerebrovascular contractile receptors and delayed cerebral ischemia, and improves outcome after subarachnoid hemorrhage in ratsGro K Povlsen, Lars EdvinssonPageof 33